Imprimis Pharmaceuticals announced that it ranked 12 on Deloitte’s Technology Fast 500, an annual ranking of the fastest growing North American companies in the technology, media, telecommunications, life sciences, and energy tech sectors. Rankings are based on percentage revenue growth from 2012 to 2015, during which Imprimis grew 9,616 percent.
“We are pleased to have been named among such amazing industry leaders on this year’s Fast 500 list," Mark L. Baum, CEO of Imprimis, said in the news release. "Imprimis’ rapid growth is a testament to the importance of our efforts to provide greater competition in the U.S. prescription drug market, lower consumer prices for critical medicines and provide greater access to high quality drugs for all Americans. Without our talented team’s collective commitment to our vision and dedication to our customers, this achievement would not have been possible.”
“This year’s Fast 500 winners showcase that when organizations are open to diverse perspectives and insights, they are able to create an environment for their employees and customers to see the possibilities and ingenious solutions that might lie ahead,” added Jim Atwell, national managing partner of the emerging growth company practice, Deloitte & Touche LLP. “Entrepreneurial environments foster change and innovation within businesses, and we look forward to watching these companies continue to drive change across all sectors.”
About Deloitte’s 2016 Technology Fast 500
Deloitte’s Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences and energy tech companies – both public and private – in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2012 to 2015. Overall, 2016 Technology Fast 500™ companies achieved revenue growth ranging from 121 percent to 66,661 percent from 2012 to 2015, with median growth of 290 percent.